Trial Profile
A multi-center, randomized, placebo-controlled, double blind trial of zoledronic acid and VOLT01 in patients with osteoarthritis of the knee
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 15 Jan 2015
Price :
$35
*
At a glance
- Drugs Prednisolone/zoledronic acid (Primary) ; Zoledronic acid
- Indications Osteoarthritis
- Focus Registrational; Therapeutic Use
- Sponsors Levolta Pharmaceuticals
- 15 Jan 2015 New trial record